Dinitrochlorobenzene (DNCB) immunotherapy of a recurrent conjunctival papilloma was employed successfully in a 24-year-old man. Previous attempts at electrocautery, surgical excision, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback